about
Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for AnthraxEfficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthraxEfficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease SeverityEfficacy of Single and Combined Antibiotic Treatments of Anthrax in RabbitsCombination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.The central nervous system as target of Bacillus anthracis toxin independent virulence in rabbits and guinea pigs.Preparation and evaluation of human-murine chimeric antibody against protective antigen of Bacillus anthracis.Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational AnthraxToxin-independent virulence of Bacillus anthracis in rabbits.Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal RuleA novel homogeneous immunoassay for anthrax detection based on the AlphaLISA method: detection of B. anthracis spores and protective antigen (PA) in complex samples.Effect of animal sera on Bacillus anthracis Sterne spore germination and vegetative cell growth.Passive protection against anthrax in mice with plasma derived from horses hyper-immunized against Bacillus anthracis Sterne strain.Pathology of wild-type and toxin-independent Bacillus anthracis meningitis in rabbits.Treating Anthrax-Induced Meningitis in Rabbits.
P2860
Q28384806-5577D2E3-B4D3-41F2-8150-9BAD4BB8FCF9Q28389738-2B8AFA02-4C8B-4CD4-B4B1-244D3D1EF7E1Q28390214-F50E1D29-F279-4142-9DFA-519702FB6337Q28394063-0FF3EC4F-6A3C-4001-8650-4661F8654A45Q34194627-51D9304A-2FA3-4142-9053-E944DCD05F49Q34466263-815B7451-00F3-4534-895C-32BD868E379EQ34486875-64C3ADF7-C8B1-4757-BAA1-9BA546F1F7C9Q35806278-26B7192A-4178-4156-ABE8-CECBEC0F6A59Q37287801-FC62BE7D-CE9B-45EA-8CE9-DBDA2DD8BAD5Q37453046-7866E27F-2835-47E2-93C5-56063BBF6AC1Q37594165-119C14EB-1F36-4FB2-9897-D52E12CE395FQ42276017-CB4728F7-F3B9-436F-ADC6-4DD0A501BC7CQ45401341-90E031E9-2DE8-4B99-931F-8F0163233357Q47135050-C8F41141-083A-49FB-9724-071CF2607DECQ47137747-5415E794-BA98-475C-AEAC-612F5DD0EBD8Q52584720-D91DE3EE-A28A-47DB-B9A3-7738740D05E8
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antibiotics cure anthrax in animal models.
@en
type
label
Antibiotics cure anthrax in animal models.
@en
prefLabel
Antibiotics cure anthrax in animal models.
@en
P2093
P2860
P356
P1476
Antibiotics cure anthrax in animal models.
@en
P2093
David Kobiler
Josef Schlomovitz
Nili Rothschild
Shay Weiss
Yakir Ophir
Zeev Altboum
P2860
P304
P356
10.1128/AAC.01689-10
P407
P577
2011-01-24T00:00:00Z